| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.21▼ | 1.23▼ | 1.23▼ | 1.26▼ | 1.20▲ |
| MA10 | 1.27▼ | 1.28▼ | 1.27▼ | 1.19▲ | 1.19▲ |
| MA20 | 1.27▼ | 1.23▼ | 1.21▼ | 1.20▲ | 1.33▼ |
| MA50 | 1.19▲ | 1.17▲ | 1.17▲ | 1.21▼ | 1.79▼ |
| MA100 | 1.17▲ | 1.19▲ | 1.19▲ | 1.39▼ | 1.87▼ |
| MA200 | 1.20▲ | 1.17▲ | 1.19▲ | 1.80▼ | 1.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.019▼ | -0.010▼ | -0.006▼ | 0.016▲ | 0.015▲ |
| RSI | 42.605▼ | 47.127▼ | 48.562▼ | 49.755▼ | 42.681▼ |
| STOCH | 4.496▼ | 19.255▼ | 22.547 | 65.666 | 41.525 |
| WILL %R | -100.000▼ | -100.000▼ | -96.875▼ | -56.667 | -61.333 |
| CCI | -106.166▼ | -80.421 | -68.301 | 32.854 | -40.158 |
|
Friday, May 08, 2026 03:08 PM
EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted ...
|
|
Friday, May 08, 2026 01:00 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
|
Monday, April 27, 2026 07:14 AM
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/05/26 | 1.245 | 1.245 | 1.18 | 1.20 | 127,193 |
| 08/05/26 | 1.35 | 1.35 | 1.25 | 1.30 | 158,557 |
| 07/05/26 | 1.25 | 1.37 | 1.2138 | 1.37 | 195,005 |
| 06/05/26 | 1.17 | 1.25 | 1.12 | 1.25 | 102,371 |
| 05/05/26 | 1.16 | 1.16 | 1.09 | 1.16 | 132,905 |
| 04/05/26 | 1.13 | 1.16 | 1.09 | 1.11 | 125,309 |
| 01/05/26 | 1.15 | 1.21 | 1.07 | 1.10 | 282,119 |
| 30/04/26 | 1.16 | 1.20 | 1.14 | 1.19 | 55,713 |
| 29/04/26 | 1.12 | 1.20 | 1.11 | 1.12 | 83,494 |
| 28/04/26 | 1.17 | 1.17 | 1.11 | 1.13 | 132,912 |
|
|
||||
|
|
||||
|
|